A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide

Autor: Gamberi, B. Berthou, C. Hernandez, M. Semenzato, G. Tholouli, E. Hájek, R. Caers, J. Dimopoulos, M. Minnema, M.C. Andreasson, B. Parreira, J. Crotty, G. Remes, K. Kueenburg, E. Rosettani, B. Di Micco, A. Peters, S. Bacon, P. Blau, I.W.

Introduction: Lenalidomide plus dexamethasone is effective and well tolerated in relapsed/refractory multiple myeloma (RRMM). In this observational, noninterventional European post-authorization safety study, the safety profile of lenalidomide plus d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::c0386c395852d66857b25f34b69f414b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078767

EUROPEAN PATIENT SAFETY POST-AUTHORIZATION STUDY WITH MULTIPLE REFRACTORY MYELOMA OR IN RELAPSE TREATED WITH POMALIDOMIDE IN HABITUAL PRACTICE

Autor: Payer, Ramirez A., Gamberi, B., Abildgaard, N., Vekemans, M. C., Kyriakou, C., Di Raimondo, F., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P., Plesner, T.

Publikováno v: Payer, R A, Gamberi, B, Abildgaard, N, Vekemans, M C, Kyriakou, C, Di Raimondo, F, Kueenburg, E, Di Micco, A, Rosettani, B, Atiba-Davies, M, Bacon, P & Plesner, T 2019, ' ESTUDIO POST-AUTORIZACIÓN EUROPEO DE SEGURIDAD DE PACIENTES CON MIELOMA MÚLTIPLE REFRACTARIO O EN RECAÍDA TRATADOS CON POMALIDOMIDA EN PRÁCTICA HABITUAL ', Haematologica, bind 104, nr. S3, PO-017, s. 200 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::8680fdc434761a1b81ec0bc517bc7739
https://portal.findresearcher.sdu.dk/da/publications/0ae5d5b8-759a-45ce-b834-ca8c3f938871

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment (Tx) With Pomalidomide (POM) and Low-Dose Dexamethasone (LoDEX) in Patients (Pts) With Relapsed or Refractory Multiple Myeloma (RRMM) and Renal Impairment (RI) Including Those on Dialysis

Autor: Sonneveld, P Dimopoulos, M Ramasamy, K Kueenburg, E Rosettani, B Collins, S Bacon, P Weisel, KC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::aa8e72d7bf8ebdcf0ff4ba8ce36cc82d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:2952096

P778: LONG‐TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) FROM THE MEDALIST TRIAL.

Autor: Fenaux, P., Santini, V., Komrokji, R. S., Zeidan, A., Garcia‐Manero, G., Buckstein, R., Miteva, D., Keeperman, K., Holot, N., Zhang, J., Nadal, J. A., Rosettani, B., Yucel, A., Platzbecker, U.

Publikováno v: HemaSphere; 2022 Supplement 3, Vol. 6, p673-674, 2p